Inicio › Cáncer de ovario › Wisconsin › Madison
Ensayos clínicos de Cáncer de ovario en Madison, WI
13 estudios para Cáncer de ovario buscan participantes en centros de Madison y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
ReclutandoFase 2/3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
ReclutandoFase 2
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ReclutandoFase 1/2
- University of Wisconsin Carbone Cancer Center, Madison
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
ReclutandoFase 2
- UW Health Carbone Cancer Center, Madison
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
ReclutandoFase 2
- Research Site, Madison
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
ReclutandoFase 3
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
ReclutandoFase 1
- University of Wisconsin - Carbone Cancer Center, Madison
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
ReclutandoFase 2
- University of Wisconsin, Madison
Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers
ReclutandoEstudio observacional
- UW Carbone Cancer Center, Madison
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Reclutando
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
ReclutandoFase 2
- University of Wisconsin - Carbone Cancer Center - University Hospital, Madison
Lead-212 PSV359 Therapy for Patients With Solid Tumors
ReclutandoFase 1/2
- University of Wisconsin, Madison
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
ReclutandoFase 1
- University of Wisconsin Carbone Cancer Center, Madison
Más información sobre Cáncer de ovario en MedlinePlus
Ensayos de Cáncer de ovario en otras ciudades
- Houston, TX89 estudios
- New York City, NY69 estudios
- Boston, MA61 estudios
- Los Angeles, CA50 estudios
- Nashville, TN49 estudios
- Arlington, VA46 estudios
- Philadelphia, PA44 estudios
- Columbus, OH39 estudios
- St. Louis, MO38 estudios
- Chicago, IL36 estudios
- San Antonio, TX31 estudios
- Cleveland, OH30 estudios
Otros estudios en Madison
- Cáncer de próstata29 estudios
- Cáncer del colon y del recto23 estudios
- Cáncer de seno22 estudios
- Cáncer metastásico21 estudios
- Leucemia mielógena aguda16 estudios
- Cáncer de pulmón de células no pequeñas16 estudios
- Melanoma15 estudios
- Cáncer (todos los tipos)14 estudios
- Cáncer de estómago11 estudios
- Cáncer de páncreas10 estudios
- Cáncer de pulmón10 estudios
- Mieloma múltiple9 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.